STUDIES ON ORALLY ACTIVE CEPHALOSPORIN ESTERS
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3-Methoxymethyl cephem derivatives having a 2-(2-aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamide function at C-7 (1) showed good activity against a wide variety of bacteria including some /3-lactamase producing species. The prodrug type esters of 1 exhibited a good urinary recovery after oral administration to mice and l-(isopropoxycarbonyloxy)ethyl ester (2a, CS-807) has been pre-clinically tested as an orally active cephem prodrug.
Recently, remarkable developments have been achieved with respect to /3-lactam antibiotics. The cephalosporins bearing an aminothiazole-oxime moiety at the C-7 position of the cephem nucleus, so-called third generation cephalosporms1~4) , have been developed clinically as parenteral antibiotics.
They possess a wide antimicrobial spectrum against Gram-positive and Gram-negative bacteria and an increased resistance against bacterial /3-lactamases. On the other hand, less significant developments have been achieved with orally active cephalosporins. Cephalexin (CEX) and its analogs bearing D-phenylglycine or closely related acyl side chains at the C-7 position are nowin clinical use but are less active against Gram-negative bacteria than the third generation cephalosporins5). Therefore, many efforts have been madeto afford neworally active cephalosporins exhibiting wider and stronger antibacterial activity than CEXand its analogs. Recently, orally active third generation cephalosporins, cefixime (FK027)6) and T-25887) (12d), have been reported.
The current cephalosporins clinically used for injection are not suitable for oral administration because of their low absorption from the gastro-intestinal tract. According to our experiments, cefazolin (CEZ) and cefmetazole (CMZ) (Fig. 1) , typical parenteral cephem antibiotics, each resulted in only 4 % urinary recovery after oral administration to mice.
Oneof the reasons for such low absorption could be attributed to the relatively low pKavalue of these compounds, i.e., pKa 2.2 for CEZand pKa 2.3 for CMZ,and so would almost completely exist as the unfavorable ionic form for passive absorption in the intestinal tract after oral administration. Therefore, we assumed that esterification of the carboxyl group at the C-4 position of the third generation cephem antibiotics may increase intestinal absorption of the drugs. The prodrug approach has been frequently utilized in penicillins to give a lipophilicity which is knownto be one of the important factors in the passive absorption from the intestinal tract8).
During the course of our research into orally active cephalosporins, we found that the combination of the substituent at C-3 and the ester at C-4 strongly influenced intestinal absorption. Some esters of 3-alkoxymethyl and 3-methyl derivatives exhibited better urinary recovery than those of compounds possessing other substituents at the C-3 position. In particular, 7^-[2-(2-aminothiazol- Fig. 2 ) showed a well-balanced antimicrobial activity against Gram-positive and Gram-negative bacteria and its esters exhibited excellent urinary recovery after oral administration to mice. In this paper, we describe the synthesis and the biological properties of prodrug type cephalosporin Fig. 2 ) and its related compounds.
Chemistry
The synthetic routes of the esters (2a and 2b) of 3-methoxymethyl cephem derivative (1) are shown in Scheme 1. The 3-acetoxymethyl cephem derivatives (4a and 4b) prepared by acylation of 7-aminocephalosporanic acid (7ACA)were treated with aqueous methanol in the presence of CaCl2 to give the corresponding 3-methoxymethyl cephem derivatives (5a and 5b). The chloroacetyl group of 5a was removed by treatment with thiourea in water to afford the compound 1 in 75.5% yield. Esterification of 1 with iodides (6a and 6b) gave the corresponding esters (2a and 2b).
Pivaloyloxymethyl (POM)ester (2b) was also prepared via another procedure. The dicyclohexylamine salt of 5b was treated with iodomethyl pivalate (6b) to give an ester (7) in 82%yield. The phenoxyacetyl group of 7 was removed by Chauvette's modification^. 7-Amino derivative (8) was acylated with 2-(2-formylaminothiazol-4-yl)-(Z)-2-methoxyiminoacetic acid (9) and POC13 followed by removal of the formyl group from the resulting compound to give the desired POMester (2b) in 83%yield.
The other esters (2c~2o, 12a~12h) were prepared by the esterification of the carboxylic acids (1, lla~llh) with the corresponding halides as shown in Scheme 2.
The parental eephem derivatives, lla and lib, were prepared as follows (Scheme 3). An acetyl group at C-3 of 7ACAwas removed in methanol with NaOHand the successive acylation with phenoxyacetyl chloride gave 3-hydroxymethyl cephem derivative (13) in 50.6% yield. The esterification of 13 with diphenyldiazomethane followed by chlorination of the resulting 3-hydroxymethyl cephem ester (14) with SOC12gave 3-chloromethyl derivative (15), which was treated with Nal in the usual manner; successive treatment of the resulting iodomethyl derivative with the corresponding alcohols Scheme 2. in the presence of Hg(NO3)2 H2Oafforded 3-ethoxymethyl and 3-propoxymethyl derivatives (16a and 16b). The desired cephems (lla and lib) were prepared from these compounds (16a and 16b) by removal of the phenoxyacetyl group of 16a and 16b, the acylation of the resulting 7-amino cephem derivatives with 2-(chloroacetylaminothiazol-4-yl)-(Z)- showed excellent antimicrobial activity, their esters (12e~12g)13) showed less urinary recovery than 2b and 12a~12c. The low urinary recovery of 12g and 12h could be attributed to their instability in vivo. They wouldbe converted into metabolites unable to be absorbed in the gastro-intestinal tract or biologically inactive metabolites. Among the 3-methyl and 3-alkoxymethyl derivatives (1, llal ie) whose POMesters showed high intestinal absorption after oral administration, the 3-methoxymethyl derivative (1) showed the strongest antimicrobial activity against Gram-positive and Gramnegative bacteria.
Therefore, the preparation and the biological evaluation of several kinds of esters of 1, other than POMester, were carried out ( Table 2 ). The POMester (2b) gave good recovery in urine among the acyloxyalkyl esters (2b, 2i and 2j). Of the other types of esters (2d, 2k~2m), ethoxycarbonyloxyethyl ester (2d) showed relatively high urinary recovery. The phthalidyl14) and (5-methyl-2-oxo-l,3-dioxol-4-yl)methyl15) esters of 1 (2k, 21 and 2m) showed relatively low recovery.
Subsequently, alkoxycarbonyloxyalkyl (carbonate type) esters have been further elaborated in order to improve intestinal absorption (Table 3 ). Amonga series of the compounds (2d, 2n and 2o) possessing a terminal ethyl group (R2) in the ester function, the compoundshaving a methyl or an ethyl group as Ru 2d and 2o, each gave 60%urinary recovery. Of the above, the ester 2d having a methyl substituent as Rx was better than 2o with respect to practical preparation. Fromour experiments, a methyl substituent as Rt resulted in superior urinary recovery when the drugs possessed the same terminal aklyl group (R2). Wethen studied carbonate type esters possessing a methyl groups asî n the ester function (2a, 2c~2h). According to these results, the combination of carbonate type ester and 3-methoxymethyl sub-1 §1 a Determined with an inoculum of 107 cfu/ml. b Urinary recovery was determined by disk method on nutrient agar using Bacillus subtilis ATCC6633 as a test strain after oral administration of POM esters (50 mg/kg as a parental cephalosporin) in sic ddY (SPF) mice (n=5, 0~24 hours). was hydrolyzed rapidly in a homogenate of the small intestine and in a serum of rats in vitro, and 1 was found in the blood of the portal vein after oral administration of 2a to rats. The serum levels of 1 and CEXafter oral administration of 2a and CEXare shown in Table 4 . l-(Isopropoxycarbonyloxy)ethyl ester (2a), CS-807, exhibited high Table 3 . Urinary recovery (% of dose) of 1 after oral administration of carbonate type esters (2a, 2c~2h, 2n and 2o) to mice. Urinary recovery was determined by the same method as described in Table 1 . a Measured as 1. Method and materials were the same as in the determination of urinary recovery as described in Table 1 . NT: Not tested. serum levels and good urinary recovery, which were on a par with CEX.
Exp erimenta l IR spectra were recorded on a Japan Spectroscopic Co., Ltd., IRA-2 spectrometer. NMRspectra were determined on a Varian EM-360 (60 MHz) spectrometer using TMSas an internal standard.
The melting points were determined using Yanagimoto micro-melting point apparatus. The melting points and the boiling points are uncorrected.
To a solution of 4a (26 g) and NaHCO3(4.1 g) in water (80 ml) were added methanol (170 ml) and CaCl2*2H2O (375 g) successively at room temp. After stirring for 75 minutes at 70°C, the mixture was poured into ice-water (500 ml). The mixture was acidified with cone HC1 (10 ml) and extracted with EtOAc (2 x 500 ml). The extracts were combined and washed with brine. The organic layer was extracted with 10% aq K2HPO4(350, 150 and 100 ml successively).
The aqueous layers were combined and extracted with EtOAc (2 x 500 ml) after acidification with HC1. The organic layers were washed with brine and dried (MgSO4), and coned to about 1/5 volume to yield a precipitate. The mixture was allowed to stand at room temp for 3 hours. 
To a solution of 5a (8 g) and NaHCO3(4g) in water (20ml) was added thiourea (1.82g) at room temp. After stirring for 14 hours at the same temp, the resulting precipitate was filtered off and cone HC1(20 ml) was added to the solution on an ice bath with stirring. The resulting precipitate was filtered off again. The filtrate was adjusted to about pH 2-3 with aq NaOHto yield a precipitate which was collected by filtration to give 1 (5.12 g) 1-Iodoethyl Isopropyl Carbonate (6a) To a mixture of ethyl chloroformate (280 ml) and sulfuryl chloride (260 ml) was added benzoylperoxide (1 g) at room temp. After being refluxed for 7.5 hours, the mixture was distilled to give 1-chloroethyl chloroformate (217 g) (boiling range 119~140°C). To a solution of 1-chloroethyl chloroformate (317 g) in CH2C12 (2,000 ml) was added isopropyl alcohol (397 ml) under cooling with stirring. Pyridine (230 ml) was added dropwise to the solution over 20 minutes and the mixture was stirred for 30 minutes at the temp. The reaction mixture was washedsuccessively with water (500 ml), brine (500 ml) and 5% aq KHSO4, and dried (MgSOJ. The solvent was removed and the resulting liquid was distilled under reduced pressure to give 1-chloroethyl isopropyl carbonate (228 g). To a solution of 1-chloroethyl isopropyl carbonate (102 g) in benzene (1,000 ml) were added Nal (200 g) and 18-crown-6 (5 g) and the mixture was refluxed overnight. The mixture was washed with water and 5% aq Na2S2O3. The organic layer was dried (MgSO4) and coned in vacuo to give (Table  6 ). Anal Calcd for C21H27N5O9S2: C 45.24, H 4.88, N 12.56, S ll.50.
Found: C 45.27, H 5.07, N 12.30, S ll.44. The esters (2c~2j, 2m~2o) were prepared in a procedure similar to that described above. NMR data are listed in Table 6 .
Phthalidyl 7/3 -[2 -(2-Aminothiazol -4 -yl) -(Z) -2 -methoxyiminoacetamido] -3 -methoxymethyl-3 -cephem-4-carboxylate (2k and 21)
Sodium salt of 1 (500 mg) was dissolved in DMSO(5 ml) and phthalidyl bromide (356 mg) was added to the solution at room temp. After stirring for 15 minutes, the mixture was diluted with EtOAc (100 ml) and washed with aq NaHCO3 and brine. The organic layer was dried (MgSO4)and coned in vacuo to give a mixture of 2k and 21. The The esters (2a, 2c-2e, 2g, 2h and 2o) were mixtures of diastereoisomers derived from the asymmetric carbon in the ester function. The ester 2f was a mixture of two pairs of diastereoisomers derived from the two asymmetric centers in the ester group. The esters, 2k and 21, are diastereoisomers with regard to the asymmetriccarbon in the ester function.
mixture was separated on a silica gel column (EtOAc -cyclohexane, 4 : 1) to give 2k (236 mg) and 21 (188 mg), respectively. *H NMR (Table 6 ). 7i5-Phenoxyacetamido-3 -methoxymethyl-3 -cephem-4-carboxylic Acid (5b) To a solution of 4b (10 g) in water (33 ml) were added methanol (67 ml) and CaCl2 (100 g) at room temp. After stirring for 45 minutes at 70°C, the mixture was poured into ice-water (100 ml) and treated in a manner similar to that mentioned in the preparation of 5a. The final extracts were coned in vacuo to give a yellow solid (5b) (7.15 g). The solid (5b) was dissolved in EtOAc (50ml) and dicyclohexylamine (3. Further purification was carried out as follows. The dicyclohexylamine salt of 5h (2 g) was suspended in a mixture of water (50 ml) and EtOAc (50 ml), and the mixture was acidified with HC1. An insoluble material was filtered off and the EtOAc layer was separated. The organic layer was washed with brine and dried (MgSO4). The solvent was removed and the resulting solid was chromatographed on a silica gel column (EtOAc -EtOH -H2O, 5 :2 : 1) to give 5b (1.28 g) in 94.7% yield. IR (Nujol) cm"1 1790 Q3-lactam C=O); 2H NMR(CDC13) d 3.38 (3H, s, OCH3 Pivaloyloxymethyl 7fi-Phenoxyacetamido-3-methoxymethyl-3 -cephem-4-carboxylate (7) To a solution of the dicyclohexylamine salt of 5b (15 g) in A^,AT-dimethylacetamide (70 ml) was added iodomethyl pivalate (6b) (7.9 g) at room temp. After stirring for 15 minutes, EtOAc (200 ml) was added and the resulting precipitate was filtered off. The filtrate was washed with water, aq NaHCO3 and brine successively. The organic layer was dried (MgSO4)and coned in vacuo. The residue was chromatographed on a silica gel column («-hexane -EtOAc, 1 : 1) to give 7 (10.9 g) in .p-Toluenesulfonic Acid Salt of Pivaloyloxymethyl 7ff-Amino-3-methoxymethyl-3-cephem-4-carboxylate (8) To a solution of 7 (20 g) were added pyridine (6.6 ml) and PC15 (12.7 g) at -50°C with stirring. The cooling bath was removed and the mixture was stirred at room temp for 1 hour. After cooling the reaction mixture to -20°C, methanol (20 ml) was added. The mixture was then stirred for 1 hour at room temp again and coned in vacuo. The residue was dissolved in EtOAc (300 ml) and the solution was washed with ice-cooled aq NaHCO3twice and then brine. The organic layer was dried (MgSO4) and coned. The residue was dissolved in EtOAc (100ml) and a solution of^-toluenesulfonic acid mono hydrate (7.7 g) in EtOAc (50 ml) was added to the solution. The resulting precipitate was collected by filtration to give 8 (ll.2 g) in 52% yield. MP 160~170°C (dec); IR (Nujol) cm"1 1790 03-lactam C=O); *H NMR (DMSO-</6) 8 1.20 (9H, s, tert-butyl), 2.30 (3H, s, CH3), 3.26 (3H, s, OCH3), 3.69 (2H, br s, 2-CH2), 4.28 (2H, s, 3' -CH2), 5.1-5.6 (2H, m, 6-H and 7-H To a solution of 8 (3.93 g), 9 (1.88 g) and diethylaniline (3.65 g) in CH2C12 (60ml) was added POC13 (1.27 g) under cooling with stirring. After 30 minutes the solvent was removed and displaced with EtOAc (200 ml). The solution was washed with 5 % HC1 twice, ice-cooled aq NaHCO3and brine successively. The organic layer was dried (MgSO4)and coned in vacuo. The crude product was chrornatographed on a silica gel column (EtOAc-CHC13, 3 : 1) to give 10 (3.95 g) as a colorless solid. 
A): The esterification of 1 (3.1 g) was carried out with dicyclohexylamine (1.45 g) and 6b (2 g) in A^A^-dimethylacetamide (30 ml) by the method mentioned in the preparation of 2a.
Purification by silica gel column chromatography (EtOAc -CHC13, 4 : 1) gave 2b (2.99 g) in 76% yield. IR (Nujol) cm"1 1785 (/3-lactam C=O), 1680 (amide C=O). XH NMR( B): To a suspension of 10 (3 g) in methanol (30 ml) was added cone HC1 (0.9 ml) at room temp and the mixture was stirred for 30 minutes at 40°C to give a solution. The solution was diluted with EtOAc (150 ml) and washed with ice-cooled aq NaHCO3and brine. The organic layer was dried (MgSO4)and coned in vacuo. The residue was chromatographed on a silica gel column (EtOAc) to give 2b (2.53 g) in 88.7% yield.
7/3-Phenoxyacetamido-3-hydroxymethyl-3 -cephem-4-carboxylic Acid (13) To a suspension of 7ACA(200 g) in methanol (368 ml) was slowly added 1 n NaOH(735 ml) at -5°C with stirring. An additional portion of 1 n NaOH(735 ml) was added to the resulting solution and stirred for 30 minutes at 0-5°C. Acetone (500ml) was added to the mixture and then phenoxyacetyl chloride (17 g) was added dropwise to the mixture over a period of 30 minutes at 0-5°C.
After washing the mixture with EtOAc(1,000 ml), the aqueous layer was acidified with cone HC1 (83 ml) and extracted twice with EtOAc (1,000 ml). The extract was combined and coned to a small volume without drying to give precipitate. The precipitate was collected by filtration to give 13 Diphenylmethyl 7fi-Phenoxyacetamido-3 -hydroxymethyl-3-cephem-4-carboxylate (14) To a solution of 13 (64.88 g) was added a solution of diphenyldiazomethane (38 g) in EtOAc (100 ml) at 5°C. The mixture was stirred for 4 hours at the same temp and the solvent was removed. THF(500 ml) was added to the residue and insoluble material was filtered off. The filtrate was coned MAR. 1987 to a small volume to give crystals. EtOAc (500 ml) was added to the mixture which was then allowed to stand on an ice bath for 1 hour. Diphenylmethyl 7i6-Phenoxyacetamido-3 -ethoxymethyl-3-cephem-4-carboxylate (16a) To a solution of 15 (4.48 g) in acetone (120 ml) was added Nal (1.31 g) at room temp with stirring. The mixture was allowed to stand at the same temp for 1 hour. After removing the solvent, EtOAc was added to the residue and washed with water and brine, and dried (MgSO4). The solvent was removed in vacuo to give the corresponding iodomethyl derivative (5.17 g). To a suspension of the iodomethyl derivative (5 g) in ethanol was added a suspension of Hg(NO3)2 H2O (2.67 g) in CH3CN (120 ml) and stirred for 20 minutes at room temp. An insoluble material was filtered off and the filtrate was poured into water. The aqueous layer was extracted with EtOAcand washed with water, and dried (MgSO4).The solvent was removed and the residue was purified on a silica gel column (EtOAccyclohexane, 1 :2) to give 16a (3.12g) Diphenylmethyl 7/3-Phenoxyacetamido-3-propoxymethyl-3 -cephem-4-carboxylate (16b) The preparation of 16b was carried out by a method similar to that described above. XHNMR ethoxymethyl-3-cephem-4-carboxylic Acid (l la) The removal of the phenoxyacetyl group of 16a (1.117 g) was carried out by a method similar to that described in the preparation of 8 to give diphenylmethyl 7^-amino-3-ethoxymethyl-3-cephem-4-carboxylate (345 mg) in 40.6% yield. The 7-amino derivative (345 mg) in CH2C12 (4 ml) was acylated by the usual manner using 2-(chloroacetylaminothiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride, which was prepared from the corresponding acid (271 mg), (COC1)2 (124 mg) and triethylamine (99 mg) in CH2G12by Engel's modification1*0 , in the presence of diethylaniline (0.35 ml) to give the acylated compound, diphenylmethyl 7/3-[2-(2-chloroacetylaminothiazol-4-yl)-(Z )-2-methoxyiminoacetamido]-3-ethoxymethyl-3-cephem-4-carboxylate (147 mg). To a solution of the acylated compound (147 mg) in iV,iV-dimethylacetamide (1.5 ml) was added thiourea (32 mg) and stirred for 3 hours at room temp. The reaction mixture was neutralized with aq NaHCO3and stirred for additional 2 hours. The reaction mixture was diluted with EtOAcand the mixture was washed with 5%aq NaHCO3,water (x 3) and brine, and dried (MgSO4). The solvent was removed and chromatographed on a silica gel column (EtOAc -cyclohexane, 3 : 2) to give a solid (73 mg). The solid was dissolved in anisole (0.7 ml) and trifluoroacetic acid (0.7 ml) was added to the solution at -15°C with stirring. After stirring for 20 minutes at room temp the solvent was removed and the residue was triturated with diisopropyl ether to give trifluoroacetic acid salt of lla (55mg). XHNMR(acetone-J6) 3 1.14 (3H, t,/=7 Hz, 
